China PTCA Balloon Market Investment Report, 2014-2016
  • Sep.2014
  • Hard Copy
  • USD $2,500
  • Pages:114
  • Single User License
    (PDF Unprintable)       
  • USD $2,350
  • Code: ZLC008
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $3,700
  • Hard Copy + Single User License
  • USD $2,700
      

PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. Therefore, the development of PTCA balloon industry is closely related to that of PCI.

As national economy develops and people’s living standard improves, the number of patients receiving PCI has been on the rise year by year, and totaled 454,505 cases in China in 2013, up 16.9% from a year earlier. Demand for PTCA balloon during the same period reached 1.186 million sets, rising by 13.8% on a year-on-year basis.

Despite year-on-year growth in the number of PCI cases in China, the penetration is still very low. In 2013, 309.42 per 1 million were people receiving PCI treatment in China, compared with 1800 cases in the United States, showing a vast space for development of the Chinese PCI market and a bright future for PTCA balloon industry. It is expected that China’s demand for PTCA balloon will hit 1.824 million sets by 2016.

At present, the Chinese PTCA balloon market is still dominated by foreign companies, such as Medtronic, Abbott, Boston Scientific, Goodman, Terumo, etc. However, local Chinese PTCA balloon companies are improving their competitiveness, with overall market share rising to about 40% in 2013 as opposed to 20% in 2009.

Local Chinese PTCA balloon companies include Lepu Medical, MicroPort, JW Medical, Yinyi, Neich Medical (Shenzhen), Synexmed, Sino Medical and Demax Medical, of which Lepu Medical, MicroPort, Neich Medical (Shenzhen) and Sino Medical manufacture both PTCA balloon catheter for delivering coronary stent and PTCA balloon, JW Medical manufactures only PTCA balloon for delivering coronary stent, and Demax Medical produces only PTCA balloon.

MicroPort is a bellwether in the Chinese coronary stent system market. On Jan. 20, 2014, MicroPort announced that it would acquire drug-eluting stent-related assets of Cordis under Johnson & Johnson. After the acquisition is completed, MicroPort’s share in drug-eluting stent market will rise by over 10%. This will also promote company’s business development of PTCA balloon for delivering coronary stent. MicroPort now can manufacture more than 200,000 sets of PTCA balloon annually.

Lepu Medical is a leading player in China PTCA balloon industry. The company now has PTCA balloon dilatation catheter capacity of 100,000 sets and coronary stent delivery system capacity of 170,000 sets.

冠脉 英文_副本.jpg

China PTCA Balloon Catheter Market Investment Report, 2014-2016 focuses on the following:
20120114.gifOperating environment of the Chinese PTCA balloon market, including macro environment, policy climate, medical & health care level and status quo of China medical device industry;
20120114.gifOverview of the Chinese PTCA balloon market, covering status quo, development bottlenecks, supply & demand, competitive landscape and development outlook and forecast;
20120114.gifInvestment in the Chinese PTCA balloon market, including favorable and unfavorable factors, economic benefit and site selection of plants;
20120114.gifOperation and PTCA balloon business of 5 foreign and 9 Chinese PTCA balloon companies.

1. Concepts Related to PTCA Balloon Industry
1.1 Definition and Classification of PTCA Balloon
1.2 Definition and Classification of Interventional Medical Device
  
2. Operating Environment of Chinese PTCA Balloon Market 
2.1 Macro Environment
2.2 Policy Climate
2.3 Medical & Health Care Level
2.4 Status Quo of China Medical Device Industry

3. Overview of Chinese PTCA Balloon Market
3.1 Status Quo
3.2 Development Bottleneck
3.3 Supply & Demand
3.3.1 Demand
3.3.2 Supply 
3.4 Competitive Landscape
3.5 Development Outlook and Forecast

4. Investment in Chinese PTCA Balloon Market
4.1 Favorable Factors
4.1.1 Strong Support by National Industrial Policy
4.1.2 Financial Incentives
4.1.3 Expanding Market Demand
4.1.4 Increasingly Standardized Market
4.2 Unfavorable Factors
4.2.1 Mounting Risk of Price Drop
4.2.2 Shortage of Related Production Materials and Equipment
4.2.3 Foreign Non-Tariff Barriers
4.3 Economic Benefit
4.4 Site Selection of Plants
4.4.1 Chengdu
4.4.2 Hangzhou
4.5 Construction of GMP Plant

5. Major Chinese Companies
5.1 Lepu Medical
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 PTCA Balloon Business
5.1.6 R&D and Investment
5.1.7 Forecast and Outlook
5.2 MicroPort
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 PTCA Balloon Business
5.2.5 R&D and Investment
5.2.6 Forecast and Outlook
5.3 JW Medical
5.3.1 Profile
5.3.2 PTCA Balloon Business
5.4 Dalian Yinyi
5.4.1 Profile
5.4.2 PTCA Balloon Business
5.5 Neich Medical (Shenzhen)
5.5.1 Profile
5.5.2 PTCA Balloon Business
5.6 SCW Medicath
5.6.1 Profile
5.6.2 PTCA Balloon Business
5.7 Synexmed
5.7.1 Profile
5.7.2 PTCA Balloon Business
5.8 Sino Medical
5.8.1 Profile
5.8.2 PTCA Balloon Business
5.9 Demax Medical (Beijing)
5.9.1 Profile
5.9.2 PTCA Balloon Business

6. Major Foreign Companies
6.1 Medtronic
6.1.1 Profile
6.1.2 Operation
6.1.3 PTCA Balloon Business
6.1.4 Operation in China
6.2 Boston Scientific
6.2.1 Profile
6.2.2 Operation
6.2.3 PTCA Balloon Business
6.2.4 Operation in China
6.3 Abbott
6.3.1 Profile
6.3.2 Operation
6.3.3 PTCA Balloon Business
6.3.4 Operation in China
6.4 Terumo
6.4.1 Profile
6.4.2 Operation
6.4.3 PTCA Balloon Business
6.4.4 Operation in China
6.5 B. Braun Melsungen
6.5.1 Profile
6.5.2 Operation
6.5.3 PTCA Balloon Business
6.5.4 Operation in China

Main Devices Used for PCI
OTW Balloon Catheter Diagram
Monorail/Rapid Exchange Balloon Catheter Diagram
Classification of Interventional Medical Device
China’s GDP and YoY Growth Rate, 1985-2013
Health Costs and % of GDP in China, 1980-2013
Per Capita Health Costs and YoY Growth Rate in China, 2006-2013E
Number of People 65 and Over and % of Total Population in China, 2004-2013
Laws and Regulations about Medical Device Industry in China
Industry Policies Concerning PTCA Balloon Industry
Number of Medical Institutions and Sickbeds in China, 2012-2013
Medical Service Quantity of Health Care Facilities in China, 2012-2013
Usage of Sickbeds in China’s Medical Institutions, 2012-2013
Total Industrial Output Value and YoY Growth Rate of China Medical Device Industry, 2005-2013E
Sales and YoY Growth Rate of China Medical Device Industry, 2005-2013E
Market Share of Home-made Coronary Drug-eluting Stent System in China, 2009-2013
Number of PCI Cases and Growth Rate in China, 2011-2013
Coronary Stent Implantation and Usage Percentage of Drug-eluting Stent in China, 2011-2013
China’s Demand for PTCA Balloon, 2011-2013
Major Coronary Stent System Brands and Their Market Shares in China (by Consumption), 2013
Market Share Comparison between Home-made and Imported PTCA Balloon, 2013
Number of PCI Cases and Growth Rate in China, 2011-2016E
Local Regulations on Circulation and Usage of Interventional Medical Devices
Market Prices of Major PTCA Balloon Catheter Brands in China, 2008/2013E
Operating Revenue and Total Profit of Artificial Limb, Artificial Organ and Interventional Medical Device Manufacturing, 2009-2014
Chengdu’s GDP and YoY Growth Rate, 2009-2013
Chengdu’s GDP and Percentage by Industry, 2013
Chengdu’s Total Fixed Asset Investment and YoY Growth, 2009-2013
Chengdu’s Total Fixed Asset Investment Breakdown by Industry, 2013
Actual Use of Foreign Direct Investment and YoY Growth in Chengdu, 2009-2013
Chengdu’s Total Industrial Output Value and YoY Growth, 2009-2013
Chengdu’s Industrial Value Added and YoY Growth, 2009-2013
Chengdu’s Industrial Value Added by Sector and Percentage, 2013
Average Wage of Employees in Chengdu, 2009-2013
List of Industrial Parks in Chengdu
Unit Price of Electricity in Chengdu Hi-Tech Industrial Development Zone
Unit Price of Water in Chengdu Hi-Tech Industrial Development Zone
Unit Price of Gas in Chengdu Hi-Tech Industrial Development Zone
International Air Transport Price Comparison between Chengdu and Shanghai & Hong Kong
International Air Transport Incidentals Comparison between Chengdu and Shanghai
List of Time and Prices for Railway Transportation from Chengdu to Shanghai/Shenzhen
Hangzhou’s GDP and YoY Growth, 2005-2013
Hangzhou’s Total Industrial Output Value and YoY Growth, 2005-2012
Hangzhou’s Total Fixed Asset Investment and YoY Growth, 2005-2013
Average Wage of On-post Employees in Hangzhou, 2009-2013
List of Development Zones in Hangzhou
Main Preferential Policies in Export Processing Zone of Hangzhou Economic and Technological Development Zone Compared with Other Regions
Unit Price of Electricity in Hangzhou Economic and Technological Development Zone
Unit Price of Water in Hangzhou Economic and Technological Development Zone
Unit Price of Gas in Hangzhou Economic and Technological Development Zone
Cost Estimation for 100,000-grade Clean Workshop in China
Distribution of Lepu Medical’s Subsidiaries
Revenue, Net Income and Gross Margin of Lepu Medical, 2009-2013
Revenue Breakdown of Lepu Medical (by Product), 2009-2013
Revenue Breakdown of Lepu Medical (by Region), 2009-2013
Gross Margin of Lepu Medical (by Product), 2009-2013
Technical Parameters of Lepu Medical’s Hoper? PTCA Balloon Dilatation Catheter
Models and Parameters of Lepu Medical’s GRIP? High Pressure Papillary Balloon Dilatation Catheter
Balloon Compliance of Lepu Medical’s Nano plus? and Partner? Stent Delivery System
Specifications of Lepu Medical’s Biguard? Stent System
Balloon Compliance of Lepu Medical’s Biguard? Stent Delivery System
Balloon Compliance of Lepu Medical’s GuReater? Stent Delivery System 
R&D Costs and % of Total Revenue of Lepu Medical, 2010-2013
Projects with Funds from IPO or Refinancing and Completion Status of Lepu Medical
Revenue and Net Income of Lepu Medical, 2012-2016E
Revenue, Net Income and Gross Margin of MicroPort, 2009-2013
Revenue Breakdown of MicroPort (by Product), 2011-2013
Revenue Structure of MicroPort (by Product), 2011-2013
Revenue Breakdown of MicroPort (by Region), 2009-2013
Revenue Structure of MicroPort (by Region), 2009-2013
Revenue from Cardiovascular Interventional Products and % of Total Revenue of MicroPort, 2011-2013
Specifications of MicroPort’s Pioneer? Balloon Dilatation Catheter
Specifications of MicroPort’s Hercules? Balloon Dilatation Catheter
R&D Costs and % of Total Revenue of MicroPort, 2009-2013
Revenue and Net Income of MicroPort, 2012-2016E
Balloon Compliance of JW Medical’s EXCEL Drug-eluting Stent Delivery System 
Features of Dalian Yinyi’s Balloon Dilatation Catheters 
Balloon Compliance of Dalian Yinyi’s Pre-dilatation Balloon Catheter Series
Balloon Compliance of Dalian Yinyi’s Post-dilatation Balloon Catheter Series
Specifications and Models of Dalian Yinyi’s Balloon Dilatation Catheters
Compliance of Neich Medical (Shenzhen)’s Sapphire? II Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s PCTA Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s Sapphire? NC High Pressure Balloon Dilatation Catheter
Compliance of Neich Medical (Shenzhen)’s Scoreflex? Dual-wire Balloon Dilatation Catheter
SCW Medicath’s PTCA Balloon Dilatation Catheters
Features and Advantages of SCW Medicath’s PTCA Balloon Dilatation Catheters
Technical Parameters of SCW Medicath’s PTCA Balloon Dilatation Catheters
Common Specifications and Models of SCW Medicath’s PTCA Balloon Dilatation Catheters
Compliance of SCW Medicath’s Standard Balloons
Compliance of SCW Medicath’s High Pressure Balloons
Main Technical Parameters of Synexmed’s Advancer? PTCA Balloon Catheter
Compliance of Synexmed’s Advancer? PTCA Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Plus? PTCA/CTO Balloon Catheter
Balloon Compliance of Synexmed’s Advancer Plus? PTCA/CTO Balloon Catheter
Main Technical Parameters of Synexmed’s Advancer Hp? High Pressure Balloon Catheter
Balloon Compliance of Synexmed’s Advancer Hp? High Pressure Balloon Catheter
Balloon Compliance of Sino Medical’s BuMA? Delivery System
Specifications and Models of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon
Balloon Compliance of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Diagram for Balloon Passing External Diameter of Sino Medical’s Sleek PTCA Rapid Exchange Dilatation Balloon Catheter
Technical Parameters of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheter
Specifications and Models of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheter
Balloon Compliance of Demax Medical’s Gusta? PTCA Balloon Dilatation Catheter
Technical Parameters of Demax Medical’s Gusta?NC Noncompliant Balloon Dilatation Catheter
Specifications and Models of Demax Medical’s Gusta?NC Noncompliant Balloon Dilatation Catheters
Balloon Compliance of Demax Medical’s Gusta?NC Noncompliant Balloon Dilatation Catheters
Revenue and Net Income of Medtronic, FY2009-FY2013
Revenue Breakdown of Medtronic (by Product), FY2009-FY2013
Revenue Structure of Medtronic (by Product), FY2009-FY2013
Revenue from Coronary Products and % of Total Revenue of Medtronic, FY2009-FY2013
Specifications of Medtronic’s Sprinter Legend Semicompliant Balloon
Specifications of Medtronic’s Sprinter OTW Semicompliant Balloon
Specifications of Medtronic’s NC Sprinter Rapid Exchange Noncompliant Balloon
Specifications of Medtronic’s Sprinter Legend OTW Semicompliant Balloon
Revenue, Net Income and Gross Margin of Boston Scientific, 2009-2013
Revenue Breakdown of Boston Scientific (by Division), 2009-2013
Revenue Breakdown of Boston Scientific (by Region), 2009-2013
Revenue from Cardiovascular Division and YoY Growth of Boston Scientific, 2009-2013
Classification, Performance and Application of Boston Scientific’s PTCA Balloon
Revenue, Net Income and Gross Margin of Abbott, 2009-2013
Revenue Breakdown of Abbott (by Product), 2009-2013
Revenue Structure of Abbott (by Product), 2009-2013
Revenue from Cardiovascular Products and % of Total Revenue, 2009-2013
Models and Specifications of Abbott’s TREK&MINI TREK Balloon
Models and Specifications of Abbott’s NC TREK Balloon
Revenue and Net Income of Terumo, FY2010-FY2013
Revenue Breakdown of Terumo (by Business), FY2010-FY2013
Revenue Breakdown of Terumo (by Region), FY2010-FY2013
R&D Costs and % of Total Revenue of Terumo, FY2010-FY2013
Revenue from Cardiovascular Business and % of Total Revenue of Terumo, FY2010-FY2013
PTCA Balloon Output and YoY Growth of Terumo, FY2009-FY2013E
Terumo’s Branch Companies in China and Their Main Businesses
Terumo’s Presence in China
Revenue, Net Income and Gross Margin of B. Braun Melsungen, 2009-2013
Revenue Breakdown of B. Braun Melsungen (by Division), 2009-2013
Revenue Breakdown of B. Braun Melsungen (by Region), 2009-2013
Models and Serial Numbers of B. Braun Melsungen’s SeQuent? Please PTCA Balloon
Models and Serial Numbers of B. Braun Melsungen’s SeQuent? Neo PTCA Balloon

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- www.researchinchina.com All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号